Valeant Pharmaceuticals To Participate In Healthcare Conferences

LAVAL, Quebec, Nov. 10, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. VRX VRX today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences:

  • Stifel 2016 Healthcare Conference on Tuesday, November 15, 2016 at 8:00 a.m. ET at the New York Palace Hotel;
  • Guggenheim 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016 at 11:45 a.m. ET at the Intercontinental Boston; and,
  • BMO Prescriptions for Success Healthcare Conference on Wednesday, December 14, 2016 at 1:30 p.m. ET at the InterContinental Barclay Hotel in New York City.

A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/investor-relations/events-and-presentations/default.aspx 

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Contact Information:
Investors:
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)

Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080

Valeant Pharmaceuticals International, Inc.

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-participate-in-healthcare-conferences-300360589.html

SOURCE Valeant Pharmaceuticals International, Inc.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!